Sichuan pharmaceutical companies are showing off!

According to data from Meinenet, there are currently 31 new registered classifications under review by Better Pharmaceuticals, which will be deemed to have passed the consistency evaluation after being approved for production
.
Among them, there are 9 and 7 anti-infective drugs for respiratory system and systemic use respectively
.
No first imitation (including the first imitation of the dosage form) has been approved for 9 varieties, and Better Pharmaceuticals will compete with a number of pharmaceutical companies for the first imitation
.

In terms of supplementary applications for consistency evaluation, 10 products of Better Pharmaceutical are under review and approval
.
Except for digoxin tablets, the other varieties are injections
.
Four varieties of dexamethasone sodium phosphate injection, digoxin tablets, amikacin sulfate injection, and ozagrel sodium for injection were first declared by Better Pharmaceuticals, and it is likely to become the first company to pass the review
.